Congress news
ESMO Breast Cancer Congress 2019 | Breaking news
The 1st ESMO Breast Cancer annual congress took place from 2-4 May 2019 in Berlin, Germany with the aim of bringing together breast cancer researchers and clinicians who have a specific interest in innovation and care. Several reports were issued during the congress, including:
- Global HER2 testing survey raises questions about priorities for breast cancer resources: A global survey of HER2 testing has raised questions about how resources should be spent on potentially lifesaving HER2 targeted therapies for breast cancer, especially in poorer countries.
- Integrated care ahead of innovation in breast cancer: A report by Prof Giuseppe Curigliano suggesting that therapeutic innovations should go hand in hand with a multidisciplinary, fully integrated approach to patient care.
- Breast cancer in young women: good-outcomes with advised therapy: Breast cancer in young women is often characterised by more aggressive biological features as compared to those arising in older patients - but outcomes are good when guideline-recommended treatments are given, according to ESMO Spokesperson Dr. Matteo Lambertini.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
